HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ifeoluwa O Awogbindin Selected Research

kolaviron

11/2020Kolaviron protects against nigrostriatal degeneration and gut oxidative damage in a stereotaxic rotenone model of Parkinson's disease.
8/2020Kolaviron ameliorates hepatic and renal dysfunction associated with multiwalled carbon nanotubes in rats.
4/2020Kolaviron via anti-inflammatory and redox regulatory mechanisms abates multi-walled carbon nanotubes-induced neurobehavioral deficits in rats.
1/2020Kolaviron ameliorates behavioural deficit and injury to striatal dopaminergic terminals via modulation of oxidative burden, DJ-1 depletion and CD45R+ cells infiltration in MPTP-model of Parkinson's disease.
1/2019Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson's disease.
3/2017Mechanistic perspective of the oxido-immunopathologic resolution property of kolaviron in mice influenza pneumonitis.
9/2015Kolaviron Improves Morbidity and Suppresses Mortality by Mitigating Oxido-Inflammation in BALB/c Mice Infected with Influenza Virus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ifeoluwa O Awogbindin Research Topics

Disease

5Inflammation (Inflammations)
05/2021 - 09/2015
5Parkinson Disease (Parkinson's Disease)
01/2021 - 01/2019
4Body Weight (Weight, Body)
05/2021 - 11/2017
2Neuroinflammatory Diseases
01/2020 - 01/2019
2Infections
01/2019 - 03/2017
2Human Influenza (Influenza)
03/2017 - 09/2015
1COVID-19
01/2021
1Oligospermia (Oligozoospermia)
08/2020
1Hyperkinesis
01/2020
1Necrosis
01/2019
1Ulcerative Colitis
11/2017
1Colitis
11/2017
1Cytokine Release Syndrome
03/2017
1Pneumonia (Pneumonitis)
03/2017
1Diabetes Mellitus
05/2015
1Hyperglycemia
05/2015

Drug/Important Bio-Agent (IBA)

7kolavironIBA
11/2020 - 09/2015
7AntioxidantsIBA
08/2020 - 05/2015
3RotenoneIBA
11/2020 - 01/2019
3Anti-Inflammatory Agents (Anti-Inflammatories)IBA
08/2020 - 09/2015
2BiflavonoidsIBA
01/2020 - 01/2019
2Ethanol (Ethyl Alcohol)IBA
09/2019 - 11/2017
2VaccinesIBA
01/2019 - 09/2015
1Ciprofloxacin (Cipro)FDA LinkGeneric
05/2021
1SeleniumIBA
05/2021
1Viral RNAIBA
01/2021
1Phenobarbital (Luminal)FDA Link
08/2020
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2020
1Neuroprotective AgentsIBA
01/2020
1ManganeseIBA
09/2019
1Peroxidase (Myeloperoxidase)IBA
01/2019
1Luteinizing Hormone (Lutropin)FDA LinkGeneric
11/2017
1Follicle Stimulating Hormone (Follitropin)FDA Link
11/2017
1Testosterone (Sustanon)FDA Link
11/2017
1Biomarkers (Surrogate Marker)IBA
11/2017
1Anti-Infective Agents (Microbicides)IBA
03/2017
1Pharmaceutical PreparationsIBA
09/2015
1Blood Glucose (Blood Sugar)IBA
05/2015

Therapy/Procedure

1Euthanasia (Mercy Killing)
03/2017
1Intraperitoneal Injections
05/2015